RecruitingLiver TransplantHepatitis CChronic Kidney Disease
Proteogenomic Monitoring and Assessment of Liver Transplant Recipients
Eligible age
18+ yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
This study is being done to test blood, urine and tissue samples to see if this can help decide if CKD (Chronic Kidney Disease), AR (Acute Rejection) and HCV (Hepatitis C Virus) can be identified in its early stages. CKD damage to the kidneys, AR and HCV all lower the body's ability to function properly. Early detection of these conditions could assist with successful treatment and possibly lead to less repeat organ transplants.
Sponsor: Northwestern University
You may qualify if…
- ✓ 1. Male and female recipients of all races, ≥18 years of age.
- ✓ 2. Patients undergoing primary or subsequent living or deceased donor liver transplantation.
- ✓ 3. Subject and/or guardian must be able to provide informed consent.
- ✓ 4. Subject and/or guardian must be able to comply with the study protocol.
You may not qualify if…
- ✕ 1\. Inability or unwillingness of a participant and/or guardian to provide informed consent.
Where it's recruiting
Illinois
Chicago
Source: ClinicalTrials.gov · NCT01644903 · last updated 2026-05-22